Corvus Pharmaceuticals Inc (NASDAQ:CRVS)

5.41
Delayed Data
As of Jul 22
 -0.64 / -10.58%
Today’s Change
3.22
Today|||52-Week Range
11.23
+47.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization148.0K594.0K842.0K847.0K
 
 
 
 
 
 
Operating ExpensesGross Income-148.0K-594.0K-842.0K-847.0K
 
 
 
 
 
General Expenses13.6M36.4M55.7M48.4M
 
 
 
 
 
Research And Development11.4M29.4M46.3M38.6M
 
 
 
 
 
Total Operating Expenses13.8M37.0M56.5M49.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.8M-37.0M-56.5M-49.2M
 
 
 
 
 
Extraordinary Charge-17.6M0.000.000.00
 
 
Other Expenses0.00601.0K861.0K2.3M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.3M-36.4M-55.7M-46.9M
 
 
 
 
 
Net Income-31.3M-36.4M-55.7M-46.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS21.1M15.4M20.5M27.5M
 
 
 
 
 
Shares To Calculate EPS Diluted21.1M15.4M20.5M27.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$83.86-$2.36-$2.72-$1.71
 
 
 
 
 
EPS Diluted-$1.48-$2.36-$2.72-$1.71